Marcel Doerflinger is a Bellberry-Viertel Senior Medical Research Fellow and Laboratory Head in the Infection and Global Health Division at WEHI. His research focus is on understanding the regulatory processes of programmed cell death and inflammation at the host-pathogen interface of infection. His team’s projects leverage basic discovery biology and advanced in vivo models of disease for the development of novel therapeutic strategies towards translational outcomes for high impact infections including Tuberculosis, HIV, HTLV-1 and (long) COVID. Marcel has over 50 career publications, including first and last-author manuscripts in prestigious journals including Cell, Immunity, PNAS and Nature Comms. His collaborative network includes institutes across Australia, Japan, Europe and the US and the pre-clinical disease models used in his lab have supported the initiation of two international clinical trials and enabled 2x patents. When he is not found in the lab (or more often the office these days), he likes to explore Victorias and Australia’s National Parks, campgrounds and bushwalks or is looking for the next scuba diving adventure.